Hematology Oncology Services of Arkansas

Site:	Hematology Oncology Services of Arkansas
Address:
City:	Little Rock
State:	AR
Zip:	72205
Country:	USA

Phase	Trial	Trial Status [asc]	Site Status	Drug	NCT#
3	Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)	Completed	Closed	Nilotinib or Imatinib	NCT00785785